These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10775858)

  • 1. Squaric acid immunotherapy for warts in children.
    Silverberg NB; Lim JK; Paller AS; Mancini AJ
    J Am Acad Dermatol; 2000 May; 42(5 Pt 1):803-8. PubMed ID: 10775858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contact immunotherapy with squaric acid dibutylester for the treatment of recalcitrant warts.
    Lee AN; Mallory SB
    J Am Acad Dermatol; 1999 Oct; 41(4):595-9. PubMed ID: 10495383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Multiple-Resistant and/or Recurrent Cutaneous Warts With Squaric Acid Dibutylester: A Randomized, Double-blind, Vehicle-controlled Clinical Trial.
    DallʼOglio F; Luca M; Barresi S; Micali G
    Dermatitis; 2017; 28(5):308-312. PubMed ID: 28885314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of squaric acid dibutylester (SADBE) for cutaneous warts in children.
    Micali G; Nasca MR; Tedeschi A; Dall'Oglio F; Pulvirenti N
    Pediatr Dermatol; 2000; 17(4):315-8. PubMed ID: 10990585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining the efficacy and safety of squaric acid therapy for treatment of recalcitrant warts in children.
    Pandey S; Wilmer EN; Morrell DS
    Pediatr Dermatol; 2015; 32(1):85-90. PubMed ID: 25040421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contact immunotherapy with squaric acid dibutylester for warts [corrected].
    Iijima S; Otsuka F
    Dermatology; 1993; 187(2):115-8. PubMed ID: 8358098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in cytokines in patients with warts after contact immunotherapy with squaric acid dibutylester.
    Park HJ; Choi YW; Kim SH; Shin MS; Lee SW; Oh MK; Choi HY
    Clin Exp Dermatol; 2013 Oct; 38(7):775-81. PubMed ID: 23611147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive trichloroacetic acid therapy enhances squaric acid response to verruca vulgaris.
    Silverberg JI; Silverberg NB
    J Drugs Dermatol; 2012 Oct; 11(10):1228-30. PubMed ID: 23134989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunotherapy of multiple recurring warts. II. Reassessment of the use of squaric acid dibutylester (SADBE) (author's transl)].
    Claudy AL; Roche H
    Ann Dermatol Venereol; 1981; 108(10):765-7. PubMed ID: 7305218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult and paediatric contact immunotherapy with squaric acid dibutylester (SADBE) for recurrent, multiple, resistant, mucocutaneous anogenital warts.
    Dall' Oglio F; Nasca MR; D'Agata O; Micali G
    Sex Transm Infect; 2002 Aug; 78(4):309-10. PubMed ID: 12181482
    [No Abstract]   [Full Text] [Related]  

  • 11. Modified immunotherapy for alopecia areata.
    Yoshimasu T; Furukawa F
    Autoimmun Rev; 2016 Jul; 15(7):664-7. PubMed ID: 26932732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of topical immunotherapy with squaric acid dibutylester for alopecia areata in Japanese patients.
    Sakai K; Fukushima S; Mizuhashi S; Jinnin M; Makino T; Inoue Y; Ihn H
    Allergol Int; 2020 Apr; 69(2):274-278. PubMed ID: 31767273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
    Morita K; Nakamura M; Nagamachi M; Kishi T; Miyachi Y
    J Dermatol; 2002 Oct; 29(10):661-4. PubMed ID: 12433000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA): results of an open-label, paired-comparison, clinical trial.
    Dall'oglio F; Nasca MR; Musumeci ML; La Torre G; Ricciardi G; Potenza C; Micali G
    J Dermatolog Treat; 2005 Feb; 16(1):10-4. PubMed ID: 15897160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical immunotherapy in dermatology.
    Buckley DA; du Vivier AW
    Int J Clin Pract; 1999 Mar; 53(2):130-7. PubMed ID: 10344049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical therapy of alopecia areata with squaric acid dibutylester.
    Case PC; Mitchell AJ; Swanson NA; Vanderveen EE; Ellis CN; Headington JT
    J Am Acad Dermatol; 1984 Mar; 10(3):447-50. PubMed ID: 6725657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermodysplasia verruciformis: successful treatment with squaric acid dibutylester.
    Kehdy J; Erickson C; Rady P; Tyring S; Gaspari AA
    Cutis; 2015 Aug; 96(2):114-8. PubMed ID: 26367749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of cutaneous warts with squaric acid dibutylester: a decade of experience.
    Micali G; Dall'Oglio F; Tedeschi A; Pulvirenti N; Nasca MR
    Arch Dermatol; 2000 Apr; 136(4):557-8. PubMed ID: 10768664
    [No Abstract]   [Full Text] [Related]  

  • 19. Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata.
    Shimaoka Y; Hatamochi A; Hamasaki Y; Suzuki H; Ikeda H; Yamazaki S
    J Dermatol; 2008 Mar; 35(3):151-3. PubMed ID: 18346258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic approach with squaric acid dibutylester for steroid resistant-alopecia areata incognita: A pilot study of a single center.
    Starace M; Vezzoni R; Alessandrini A; Bruni F; Carpanese MA; Misciali C; Sechi A; Piraccini BM
    Dermatol Ther; 2021 Sep; 34(5):e15096. PubMed ID: 34390608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.